Amyloid-β as a Blood Biomarker for Alzheimer’s Disease: A Review of Recent Literature

Volume: 73, Issue: 3, Pages: 819 - 832
Published: Feb 4, 2020
Abstract
Alzheimer’s disease (AD), the main cause of dementia, is characterized by the aggregation of amyloid-β (Aβ). This pathophysiological process starts many years to decades before the onset of clinical symptoms. Cerebrospinal fluid analysis and amyloid positron emission tomography scans are two standa rd methods to measure brain Aβ, but their invasive nature and expense limit their usage as screening tools. Therefore, peripheral Aβ studies have...
Paper Details
Title
Amyloid-β as a Blood Biomarker for Alzheimer’s Disease: A Review of Recent Literature
Published Date
Feb 4, 2020
Volume
73
Issue
3
Pages
819 - 832
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.